Aims and scope
Molecular and Cellular Pediatrics is an international and interdisciplinary open access journal publishing peer-reviewed articles on innovative research in pediatrics.
The focus and the topics of this journal cover research areas relevant to pediatrics including rare diseases, genetic diseases, gene therapy, cardiology, endocrinology, gastroenterology, genetics, immunology, infectiology, nephrology, neurology, oncology and hematology, pneumology, metabolism, neonatology and translational medicine in pediatrics.
Molecular and Cellular Pediatrics is dedicated to exchange and discussion of current molecular and cellular concepts in pediatrics. This includes frontline reviews on the latest developments, original research articles and a forum for discussion of pathophysiological concepts including therapeutic approaches.
Molecular and Cellular Pediatrics is an official journal of the German Society of Child and Adolescent Medicine (Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V., DGKJ).
With regard to the peer-review process, the journal’s policy is in keeping with the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (www.icmje.org/recommendations).
Molecular and Cellular Pediatrics follows the Committee of Publications Ethics (COPE) - Guidelines.
All Manuscripts submitted for publication presenting results from studies on probands or patients must comply with the Declaration of Helsinki according to the author guidelines for original papers.
Why publish your article in Molecular and Cellular Pediatrics?
Molecular and Cellular Pediatrics's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Molecular and Cellular Pediatrics offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Molecular and Cellular Pediatrics and SpringerOpen.
Online publication in Molecular and Cellular Pediatrics gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Molecular and Cellular Pediatrics are included in article alerts and regular email updates.
In addition, articles published in Molecular and Cellular Pediatrics may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Molecular and Cellular Pediatrics.
Authors of articles published in Molecular and Cellular Pediatrics retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the copyright and license agreement).
For further information about the advantages of publishing in a journal from SpringerOpen, please click here.
All articles published by the Molecular and Cellular Pediatrics are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in the Molecular and Cellular Pediatrics you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the SpringerOpen copyright and license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, SpringerOpen can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Molecular and Cellular Pediatrics therefore levies an article-processing charge of £1375.00/$2150.00/€1750.00 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
All articles published in Molecular and Cellular Pediatrics are included in:
- PubMed Central
- Summon by Serial Solutions
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by SpringerOpen on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Clarivate Analytics) to ensure that articles published in Molecular and Cellular Pediatrics will be available in their databases when appropriate.
Molecular and Cellular Pediatrics operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Publication of research articles by Molecular and Cellular Pediatrics is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field. Submitted manuscripts will generally be reviewed by two to three experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. Reviewers will also be asked to indicate how interesting and significant the research is. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Molecular and Cellular Pediatrics should adhere to SpringerOpen's editorial policies.
Once your article is accepted, it will be processed by production and published shortly afterwards. In some cases, articles may be held for a short period of time prior to publication. If you have any concerns or particular requirements please contact the Journal.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Molecular and Cellular Pediatrics
Articles in Molecular and Cellular Pediatrics should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Mol Cell Pediatr [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Mol Cell Pediatr 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure.
- ISSN: 2194-7791 (electronic)